References
- 1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98(18):10344-9. DOI: 10.1073/pnas.181177898.
- 2. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki KI, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105(11):1527-36. DOI: 10.1172/JCI8296.
- 3. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97(7):3422-7. DOI: 10.1073/pnas.97.7.3422.
- 4. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, et al. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina / Novelty and Significance. Circ Res. 2011;109(4):428-36. DOI: 10.1161/CIRCRESAHA.111.245993.
- 5. Doyle B, Sorajja P, Hynes B, Kumar AHS, Araoz P a, Stalboerger PG, et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17(5):941-51. DOI: 10.1089/scd.2007.0214.
- 6. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol. 2008;45(4):530-44. DOI: 10.1016/j. yjmcc.2008.08.003.
- 7. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114-22. DOI: 10.1093/eurheartj/ehi818.
- 8. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter J a, Brewster BJ, et al. Optimizing stem cell function for the treatment of ischemic heart disease. J Surg Res. 2011;166(1):138-45. DOI: 10.1016/j.jss.2010.05.057.
- 9. Landoni G, Bignami E, Oliviero F, Zangrillo A. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth. 2009;12(1):4-9. DOI: 10.4103/0971-9784.45006
- 10. Frässdorf J, De Hert S, Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009;103(1):89-98. DOI: 10.1093/bja/aep141.
- 11. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ. Volatile anesthetic-induced cardiac preconditioning. J Anesth. 2007;21(2):212-9. DOI: 10.1007/s00540-006-0486-6.
- 12. Popescu M, Munteanu A, Isvoranu G, Suciu L, Pavel B, Marinescu B, et al. Dynamics of endothelial progenitor cells following sevoflurane preconditioning. Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):109-13.
- 13. Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, et al. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics. Anesth Analg. 2009;109(4):1117-26. DOI: 10.1213/ ANE.0b013e3181b5a277.
- 14. Sun X, Fang B, Zhao X, Zhang G, Ma H. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential. PLoS One. 2014;9(3):e90667. DOI: 10.1371/journal. pone.0090667.
- 15. Vasa M, Fichtlscherer S, Aicher a, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1-7. DOI: 10.1161/hh1301.093953.
- 16. Hibbert B, Ma X, Pourdjabbar A, Simard T, Rayner K, Sun J, et al. Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One. 2011;6(1):e16413. DOI: 10.1371/journal. pone.0016413.
- 17. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 2006;107(9):3546-54. DOI: 10.1182/ blood-2005-08-3215.
- 18. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell. 2006;124(1):175-89. DOI: 10.1016/j. cell.2005.10.036.
- 19. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005;46(9):1693-701. DOI: 10.1016/j.jacc.2005.04.066.
- 20. Hibbert B, Ma X, Pourdjabbar A, Holm E, Rayner K, Chen Y-X, et al. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res. 2009;83(1):16-23. DOI: 10.1093/cvr/cvp156.
- 21. Hirschi KK, Ingram D a., Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584-95. DOI: 10.1161/ATVBAHA.107.155960.
- 22. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z. Sevoflurane and Isoflurane Preconditioning Provides Neuroprotection by Inhibition of Apoptosis-related mRNA Expression in a Rat Model of Focal Cerebral Ischemia. J Neurosurg Anesthesiol. 2012;24(4):336-44. DOI: 10.1097/ ANA.0b013e318266791e.
- 23. Codaccioni J-L, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet B a. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology. 2009;110(6):1271-8. DOI: 10.1097/ALN.0b013e3181a1fe68.
- 24. Liu Y, Shi L, Liu C, Zhu G, Li H, Zhao H, et al. Effect of combination therapy of propofol and sevoflurane on MAP2K3 level and myocardial apoptosis induced by ischemia-reperfusion in rats. Int J Clin Exp Med. 2015 Apr 15;8(4):6427-35.
- 25. Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane Postconditioning Protects Rat Hearts against Ischemia-Reperfusion Injury via the Activation of PI3K/AKT/mTOR Signaling. Sci Rep. 2014;4:7317. DOI: 10.1038/srep07317.
- 26. Zhang YL, Yao YT, Fang NX, Zhou CH, Gong JS, Li LH. Restoration of autophagic flux in myocardial tissues is required for cardioprotection of sevoflurane postconditioning in rats. Acta Pharmacol Sin. 2014 Jun;35(6):758-69. DOI: 10.1038/aps.2014.20.
- 27. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology. 2008. p. 656-70. DOI: 10.1016/j.expneurol.2007.12.020.
- 28. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang J-A, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg [Internet]. 2008;135(4):799-808. DOI: 10.1016/j.jtcvs.2007.07.071.
- 29. Akita T, Murohara T, Ikeda H, Sasaki K-I, Shimada T, Egami K, et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest. 2003;83(1):65-73. DOI: 10.1097/01.LAB.0000050761.67879.E4.
- 30. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-6. DOI: 10.1161/01.CIR.0000039526.42991.93.